USE OF MODIFIED CELLS OF LEUKEMIC ORIGIN AND PD-L1 ANTIBODY FOR ENHANCING THE EFFICACY OF… Application WO-2023170633-A1 World Intellectual Property Organisation (WIPO) 14 Sep 2023